Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000

Heart

Volumn 92, Issue 4, 2006, Pages 453-460

  Rodriguez T ^b,d   Malvezzi, M ^a   Chatenoud, Liliana ^a   Bosetti, C ^a   Levi, F ^c   Negri, E ^a   La Vecchia, C ^a,e  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARGENTINA; ARTICLE; BRAZIL; CANADA; CEREBROVASCULAR ACCIDENT; CHILE; COLOMBIA; COSTA RICA; CUBA; DATA BASE; ECUADOR; FEMALE; GENDER; HUMAN; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; NUTRITION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUERTO RICO; SMOKING; UNITED STATES; VENEZUELA; WORLD HEALTH ORGANIZATION;

ADULT; AMERICAS; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; RISK FACTORS; SEX DISTRIBUTION;

EID: 33645227488     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.059295     Document Type: Article

References (35)

1. Ergin A, Muntner P, Sherwin R, et al. Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med 2004;117:219-27.
2. Fox CS, Evans JC, Larson MG, et al. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham heart study. Circulation 2004;110:522-7.
3. Arciero TJ, Jacobsen SJ, Reeder GS, et al. Temporal trends in the incidence of coronary disease. Am J Med 2004;117:228-33.
4. Goldman L. The decline in coronary heart disease: determining the paternity of success. Am J Med 2004;117:274-6.
5. Levi F, Lucchini F, Negri E, et al. Trends in mortality from cardiovascular and cerebrovascular accidents in Europe and other areas of the world. Heart 2002;88:119-24.
6. Lawlor DA, Smith GD, Leon DA, et al. Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis. Lancet 2002;360:1818-23.
7. La Vecchia C, Levi F, Lucchini F, et al. Trends in mortality from cardiovascular and cerebrovascular disease. Soz Praventivmed 1993;38(suppl 1):S3-71.
8. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for pinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51.
9. World Health Organization. WHO statistical information system. WHO mortality database. www3.who.int/whosis/ (accessed 12 Sept 2005).
10. World Health Organization International classification of diseases, 8th rev. Geneva: WHO, 1967.
11. World Health Organization. International classification of diseases, 9th rev. Geneva: WHO, 1977.
12. World Health Organization. International statistical classification of diseases and related health problems, 10th rev. Geneva: WHO, 1992.
13. Pan American Health Organization. Special Program for Health, Technical Information System. Regional Mortality Database, 2001. www.paho.org (accessed March 2003).
14. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.
15. Nicholls ES, Peruga, A, Restrepo HE. Cardiovascular disease mortality in the Americas. World Health Stat Q, 1993;46:134-50.
16. De Padua Mansur A, de Fatima Marinho do Souza M, Favarato D, et al. Stroke and ischemic heart disease mortality trends in Brazil from 1979 to 1996. Neuroepidemiology 2003;22:179-83.
17. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
18. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, et al. Contribution of trends in survival and coronary event rates to changes in coronary heart disease mortality: 10-year results from 37 MONICA project populations. Lancet 1999;353:1547-57.
19. Unal B, Critchley J, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-7.
20. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations. Lancet 2000;355:688-700.
21. Baigent C, Collins R, Appleby P, et al. ISIS-2 (second international study of infarct survival) Collaborative Group. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 1998;316:1337-43.
22. Antitrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;328:71-86.
23. ISIS-1 Collaborative Group. Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1, First International Study of Infarct Survival Collaborative Group. Lancet, 1986;ii, 57-66.
24. GISSI-3 Investigators. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on six-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 1994;343:1115-22.
25. Latini R, Santoro E, Masson S, et al. GISSI-3. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 trial. Heart Dis 2000;2:185-90.
26. Aversano T, Aversano LT, Passamani E, et al. Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002;287:1943-51.
27. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Comparison of Angioplasty and Prehospital Thromboysis in Acute Myocardial Infarction (CAPTIM) study group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-9.
28. The SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the stent or surgery trial): a randomised trial. Lancet 2002;360:965-70.
29. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
30. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
31. Tomassini HC, Alves MG, Claro LB, et al. [Demographic and mortality trends in Niteroi, Rio de Janeiro, Brazil, 1979 to 1997]. Cad Saude Publica 2003;19:1621-9.
32. Pan American Health Organization. Health in the Americas, 1998 edn, vol 2.Scientific publication no 569. Washington: Pan American Health Organization, 1998.
33. Messite J, Stellman SD. Accuracy of death certificate completion: the need for formalized physician training. JAMA 1996;275:794-6.
34. Lloyd-Jones DM, Martin DO, Larson MG, et al. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998;129:1020-6.
35. Ezzati M, Hoorn SV, Rodgers A, et al. Comparative Risk Assessment Collaborating Group. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003;362:271-80.